The global spine osteoarthritis pain drug market is anticipated to grow at a significant CAGR during the forecast period (2024-2031). Osteoarthritis of spine is degeneration of cartilage of discs in lower back and neck. Sometimes osteoarthritis creates gaps that give pressure on nerves leaving the spinal column. Spinal osteoarthritis tends to occur more in older people as compared to younger ones. The factors resulting causes include injury, trauma to the spine or cartilage involved genetic defect. There are various forms of drugs available for spine osteoarthritis pain such as analgesics, that are used for pain treatment. This drug class works by stopping signals in the body that creates pain. Instances of analgesics include Acetaminophen (Tylenol) and Duloxetine (Cymbalta). Acetaminophen (Tylenol) is an over-the-counter (OTC) analgesic that can be administered orally as a tablet, gel capsule, or liquid concentration. Another class of drugs known as nonsteroidal anti-inflammatory drugs (NSAIDs) is also used for the treatment of spine osteoarthritis pain.
Get Free Sample link @ https://www.omrglobal.com/request-sample/spine-osteoarthritis-pain-drug-market
Some key players operating in the market include Pfizer Inc., Eli Lilly & Co., and GlaxoSmithKline plc, among others. These players are eyeing on strengthening their position in the market by adopting various strategies such as mergers and acquisitions, partnerships and collaborations, new product launches and development in the existing product portfolio, and so on. in March 2020, Pfizer and Eli Lilly and Company announced that FDA has accepted tanezumab 2.5 mg and given Biologics License Application (BLA). It was developed for treating patients with moderate-to-severe pain caused due to osteoarthritis. Additionally, tanezumab prevents pain signals produced by muscles, organs, and skin from reaching the brain and spinal cord.
Full report of Spine Osteoarthritis Pain Drug Market available @ https://www.omrglobal.com/industry-reports/spine-osteoarthritis-pain-drug-market
Market Coverage
Segment Covered-
- By Type
- By Distribution Channel
Regions covered-
- North America
- Europe
- Asia-Pacific
- Rest of the World
Competitive Landscape: Pfizer Inc., Eli Lilly & Co., and GlaxoSmithKline plc, among others.
Key questions addressed by the report
- What is the market growth rate?
- Which segment and region dominate the market in the base year?
- Which segment and region will project the fastest growth in the market?
- How COVID-19 impacted the market?
o Deviation from the pre-COVID-19 forecast
o Most affected region and segment
- Who is the leader in the market?
- How are players addressing challenges to sustain growth?
- Where is the investment opportunity?
Global Spine Osteoarthritis Pain Drug Market Report by Segment
By Type
- Oral
- Injection
- Others
By Distribution Channel
- Online
- Offline
Reasons to Buying From us –
1. We cover more than 15 major industries, further segmented into more than 90 sectors.
2. More than 120 countries are for analysis.
3. Over 100+ paid data sources mined for investigation.
4. Our expert research analysts answer all your questions before and after purchasing your report.
For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/spine-osteoarthritis-pain-drug-market
Media Contact:
Contact Person: Mr. Anurag Tiwari
Email: anurag@omrglobal.com
Contact no: +91 780-304-0404
Company Name: Orion Market Research
About Orion Market Research
Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services. The company also offers Digital Marketing services through its subsidiary OMR Digital and Software development and Consulting Services through another subsidiary Encanto Technologies.
